Moderate obesity is known to be associated with multiple endocrine abnormalities. Less information is available on the hormonal status of patients with morbid obesity and on the effects of major weight loss. We studied 16 severely obese (BMI 40.6-69.9 kg/m 2 ) nondiabetic patients and 7 nonobese (BMI range 24.6-27.7 kg/m 2 ), sex-and age-matched healthy volunteers. During 24 h in a metabolic ward, four meals were administered and hourly blood samples were drawn from a central venous catheter for the measurement of glucose, insulin, leptin, thyrotropic hormone (TSH), growth hormone (GH) and prolactin. Insulin sensitivity was measured by a euglycaemic hyperinsulinaemic clamp. Studies were repeated 6 months after biliopancreatic diversion, a mainly malabsorptive surgical approach, which caused an average weight loss of 35±4 kg (or 26 ± 2% of initial weight). Compared with controls, patients were hyperinsulinaemic (290 ± 31 vs 88 ± 4 pmol l À1 , P ¼ 0.0002), insulin resistant (23.5±2.8 vs 52.9±4.9 mmol min À1 kg FFM À1 , P ¼ 0.0006) and hyperleptinaemic (52.5±5.8 vs 10.9±3 ng ml À1 , P ¼ 0.0002). Plasma TSH levels were increased throughout the day-night cycle (averaging 2.02 ± 0.18 vs 1.09 ± 0.19 mU ml À1 of controls, P ¼ 0.01), whereas serum GH levels were suppressed (0.46±0.10 vs 3.01±1.15, P ¼ 0.002). Following surgery, the hyperinsulinaemia and insulin resistance were fully normalized; in concomitance with a major drop in leptin levels (to 14.4±2.7 ng ml À1 , P ¼ 0.02), TSH decreased and GH increased to near-normal levels. In the whole dataset, mean 24-h leptin levels were directly related to mean 24-h TSH levels after controlling for confounders this relationship was lost only after adjusting for fat mass. We conclude that in morbid obesity leptin is a determinant of changes in pituitary function.
Introduction
In addition to the classical metabolic findings of hyperinsulinaemia and insulin resistance, multiple endocrine abnormalities are associated with obesity. 1 Thus, it has long been known that obese subjects are growth hormone (GH) deficient 2 and exhibit a blunted GH response to several stimuli; 2,3 these abnormalities are reversed by weight loss. 3 More recently, another trait of human obesity, that is, hyperleptinaemia, has been extensively investigated. 4, 5 Leptin, the ob gene product, reduces food intake and increases energy expenditure in rodents, 5 in whom defects in the ob gene or its receptors lead to severe obesity. 4 In humans, obesity mutations in the ob gene are uncommon 4 and an expanded fat mass (FM) is associated with hyperleptinaemia and leptin resistance, 6, 7 which improves with weight loss. 8 As leptin increases basal metabolic rate, several studies have investigated the relationship between leptin and thyroid hormones, with conflicting results. [9] [10] [11] In cultured adipocytes, high concentrations of thyroid hormone stimulated leptin secretion. 12 In contrast, in the rat hyperthyroidism is associated with decreased circulating leptin levels. 13 In humans, an independent effect of abnormal thyroid state on serum leptin has been difficult to demonstrate. 14 Treatment of healthy volunteers with T 3 led to hyperthyroid metabolic indices, but no change in serum leptin levels. 11 If some studies did not find different leptin levels among euthyroid, hyperthyroid and hypothyroid individuals, 10, 15 other studies found increased leptin levels in subjects with moderate hyperthyroidism 16 or lower leptin levels in hypothyroidism. 9 Recently, Kok et al. 17 reported a direct relationship between 24-h levels of thyrotropic hormone (TSH) and 24-h levels of leptin in moderately obese women. Few studies have investigated the relationships between leptin and pituitary hormones in morbid obesity and the effects on such relationships of massive weight loss by bariatric surgery, an ever more common form of treatment of this condition. [18] [19] [20] In the present study, we measured the 24-h profile of leptin and some adenohypophysal hormones in a group of severely obese subjects, before and after biliopancreatic diversion, a mostly malabsorptive type of bariatric surgery.
Methods

Subjects
The study group included 16 morbidly obese (BMI range 40.6-69.9 kg/m 2 ) nondiabetic patients and 7 nonobese (BMI range 24.6-27.7 kg/m 2 ) healthy volunteers, matched to the patients by gender and age, who served as the control group (Table 1) . At the time of the baseline study, all subjects were on a diet with the following average composition: 60% carbohydrate, 30% fat and 10% protein (at least 1 g per kg of body weight). This dietary regimen was similar in controls and obese subjects and was maintained for one week before the study. The study protocol was approved by the Institutional Ethics Committee of the Catholic University of Rome; the nature and purpose of the study were carefully explained to all subjects before they provided their written consent to participate.
Experimental design
Each subject received a baseline study, after which seven obese patients underwent biliopancreatic diversion, consisting in a partial gastrectomy with a distal Roux-en-Y reconstruction, 21 and returned 6 months later for the follow-up study. For the basal study, all subjects spent 24 h (starting at 0800 hours) in a metabolic ward. During this period, four meals were administered, for a total energy intake of 30 kcal per kg of lean body mass (20% breakfast, 40% lunch, 10% afternoon snack and 30% dinner). Diet composition was 17% protein, 35% fat and 48% carbohydrate. Hourly blood samples were drawn from a central venous catheter for the measurement of glucose, insulin, C-peptide, nonesteried fatty acids (NEFA) and leptin concentrations, and every 4 h for the measurement of TSH, GH and prolactin (PRL). Waist and hip circumference were measured by the same physician. Body composition was evaluated by measuring total body water with the use of 3 H 2 O (0.19 Bq in 5 ml of saline, administered as an intravenous bolus injection 22 ). Blood samples were drawn before and 3 h after the injection. Radioactivity was determined in duplicate on 0.5 ml of plasma in a b-scintillation counter (Canberra-Packard, Model 1600TR, Meriden, CT, USA). Corrections were made for nonaqueous hydrogen exchange; 23 water density at body temperature was assumed to be 0.99371 kg l À1 . Total body water (kg) was computed as 3 H 2 O dilution space (l) Â 0.95 Â 0.99371. On a different day, insulin sensitivity was measured by a euglycaemic hyperinsulinaemic clamp. 24 The clamp study, which was carried out after an overnight fast, consisted of 2 h of euglycaemic insulin infusion (at an insulin infusion rate of 240 pmol min À1 m
À2
). A polyethylene, 20-gauge catheter was inserted into an antecubital vein for the infusion of test substances, and another cannula was advanced into a wrist vein retrogradely. The hand was placed in a heated box (B60 1C) for the sampling of arterialized blood. Insulin was infused for 2 h and plasma glucose was maintained at the basal level by an exogenous infusion of a 20% glucose solution. Arterialized blood was sampled at 20-min intervals for insulin determination. All procedures and measures described for the basal study were repeated in the seven obese subjects participating in the follow-up study.
Analytical procedures
Plasma glucose was measured by the glucose oxidase technique on a Beckman Glucose Analyser (Beckman, Fullerton, CA, USA). Plasma insulin and leptin (Linco Research, St Charles, MO, USA) were assayed by specific radioimmunoassays. Plasma NEFA was measured spectrophotometrically (Wako, Neuss, Germany). TSH (Incstar, Stillwater, MN, USA), GH and PRL (Hybretech, San Diego, CA, USA) were measured by immunoradiometric assay.
Data analysis
Fat-free mass (FFM) was obtained by dividing total body water by 0.732. 25 FM was obtained as the difference between body weight and FFM. Whole-body glucose uptake (M value, in mmol per min per kg of FFM) was determined by averaging the exogenous glucose infusion rates during the last 40 min of the clamp after correction for changes in glucose levels in a distribution volume of 250 ml kg
À1
. To compare the diurnal and nocturnal values of the measured variables, day was taken as the mean of values between 0800 hours and 2300 Pituitary hormones and bariatric surgery S Camastra et al hours for glucose, insulin, C-peptide, NEFA and leptin concentrations and between 0800 hours and 1600 hours for TSH, GH and PRL. Night was the mean of values between 1200 hours-0700 hours for glucose, insulin, C-peptide, NEFA and leptin and between 2000 hours-0400 hours for TSH, GH and PRL.
Statistical analysis
All data are given as mean ± s.e.m. The Mann-Whitney U-test was used to compare group values, whereas treatmentinduced changes in the obese group were tested by the Wilcoxon signed-rank test. Simple and multiple regression analysis were carried out using standard techniques. Pp0.05 was considered statistically significant.
Results
As compared with controls, the obese subjects presented marked insulin resistance and were hyperinsulinaemic and hyperleptinaemic, but perfectly normoglycaemic throughout 24 h (Table 1 and Figure 1 ). Women had higher leptin levels than men whether they were lean (16.7±2.0 vs 3.2 ± 1.1 ng ml
À1
, P ¼ 0.03) or obese (61.2 ± 7.3 vs 38.2 ± 6.5 ng ml
, P ¼ 0.04). The 24-h profile of leptin levels was essentially flat except for a slight nocturnal surge (which reached statistical significance only in obese subjects, Table 2 and Figure 1) .
Obese subjects had approximately twofold higher TSH levels than controlsFalthough still in the physiological rangeFin the face of normal free thyroid hormone levels (Tables 1 and 2 ). Unlike controls, in the obese subjects nocturnal TSH concentrations were higher than diurnal values, with no sex difference. Serum GH levels were uniformly suppressed in the obese group throughout the 24-h period; a circulating GH peak was only evident in controls around midnight (Figure 2 ). PRL concentrations were higher at night than during the day, but the difference between obese and control subjects was small and did not reach statistical significance.
After 6 months of surgery, obese subjects had lost 26 ± 2% of their initial body weight, as both fat and FFM (Table 3) . Insulin sensitivity and 24-h plasma insulin levels were fully normalized, whereas 24-h plasma NEFA was higher than those in controls (Figure 1 ). Leptin and PRL had decreased to levels no longer different from those of controls, while TSH had decreased significantly but was still somewhat higher than in controls, particularly at night (Po0.05) ( Table 4) . Serum GH had increased approximately threefold after surgery, though not quite to normal levels ( Figure 2 ).
In the whole dataset, both mean 24-h leptin and mean 24-h TSH were directly related to the main indices of body mass and distributionFin particular, with BMI (r values of 0.70 and 0.58, respectively, Po0.001 for both)Fwhereas mean 24-h GH levels were inversely related to these indices (the strongest relationship being with the waist circumference, r ¼ 0.54, Po0.001). Also, mean 24-h leptin levels were inversely related to mean 24-h GH (levels r ¼ 0.40, P ¼ 0.03) and directly related to mean 24-h TSH levels ( Figure 3 ). The latter relationship remained statistically significant after adjusting for sex, BMI, waist and FFM, but was lost after adjusting for FM.
Discussion
As shown earlier in adults with moderate obesity 26 and in obese adolescents, 27 severe obesity is characterized by suppressed serum GH levels and absence of the nocturnal GH increase. In an earlier study, massive weight loss was Pituitary hormones and bariatric surgery S Camastra et al
shown to restore the dynamics of GH secretion. 28 In our patients, a 26% average weight loss following surgery did not fully normalize mean GH levels or their temporal pattern.
The discrepancy between the present results and those of Rasmussen 28 could be explained by the fact that our patients were still obese (BMI ¼ 36 kg/m 2 ) after 6 months of surgery, while theirs were only overweight. This interpretation is supported by the finding that in the whole dataset there was an inverse relation of serum GH levels to indices of adiposity, especially the waist girth. Clasey et al. 29 also reported that among 10 physiological factors known to regulate GH secretion, abdominal visceral fat and fasting serum insulin were the most important predictors of integrated 24-h GH concentrations, independently of age, gender and all other variables examined. The mechanisms underlying the dominant role of abdominal visceral fat in the control of GH concentrations remain to be elucidated. Two plausible hypotheses can be considered. Firstly, reduced GH secretion might allow for accumulation of abdominal fat, as suggested by observations in adults with GH deficiency due to hypothalamic-pituitary disease 30 and by the reduction of abdominal fat observed after GH treatment in abdominally obese men. 31 Alternatively, the raised plasma insulin levels associated with visceral fat excess 32 might provide a negative feedback on GH secretion. A positive association between visceral obesity and hyperinsulinaemia is well established. 32, 33 Our dataFshowing interrelated hyperinsulinaemia, central fat accumulation and depressed GH levels preoperatively and their joint reduction following surgeryinduced weight lossFare compatible with either explanation (or both).
As expected from the findings in moderate obesity, 34 leptin levels were elevated (fivefold) in our severely obese patients, but maintained a circadian rhythm or, at least, some nocturnal rise between midnight and 0400 hours. In the whole dataset, 24-h leptin levels were the principal correlates of 24-h GH levels and they changed consensually following weight loss. Several authors 35, 36 have reported that GH supplementation in GH-deficient adult patients decreased both body fat and plasma leptin concentrations. Moreover, Isokazi et al. 37 showed in Zucker fa/fa rats that GH directly inhibits leptin gene expression in visceral fat tissue. Thus, it is plausible that weight loss, by restoring GH secretion through reduction of insulin levels and abdominal fat, can normalize the adipocyte phenotype (at least as far as leptin secretion is concerned).
Another major finding of our study is that in morbidly obese subjects TSH levels were twofold higher than in controls around the clock and were directly related to leptin levels. A slight increase in TSH levels has been reported in adults with moderate obesity and in obese Pituitary hormones and bariatric surgery S Camastra et al children. 17, 38, 39 In rodents, leptin modulates thyroid hormone production in situations in which energy conservation through a reduction in metabolic rate is required. 40 Such effect appears to occur principally at the level of TRH neurons in the paraventricular hypothalamic nucleus (PVN). Leptin could act directly at receptors on the TRH neuron or indirectly through other hypothalamic neurons that project to the PVN. 41 In fact, following chemical ablation of the arcuate nucleus starvation fails to suppress thyroid levels. 42 Because this treatment left the TRH neurons of the PVN intact, leptin appears to regulate input from the arcuate to TRH neurons in the PVN. Indeed, the long isoform of the leptin receptor is expressed in human pituitary adenomas and in rat pituitary cells. 43, 44 Moreover, leptin expression has recently been showed in the human pituitary, both in normal tissue and in adenomas; 16 of 47 pituitary adenomas removed at trans-sphenoidal surgery showed leptin release into the incubation media at a variable level. 45 Therefore, not only is leptin stored within the pituitary, but it may also be released from pituitary cells and modulate other pituitary functions. Kim et al. 46 showed a role for the melanocortin pathway in mediating the nutritional response of the TRH neuron to leptin. The melanocortin pathway involves two ligands, agouti-related peptide, which is suppressed by leptin, and a-melanocyte-stimulating hormone, which is induced by leptin. Both are expressed in distinct neural populations in the arcuate nucleus of the hypothalamus but one receptorFthe melanocortin-4 receptorFmediates the opposing action of the two ligands. Kim et al 46 showed that a-melanocyte-stimulating hormone increases TSH levels when administered centrally to live rats and stimulates TRH release when added to hypothalamic slices. Furthermore, agouti-related peptide blocks the release of TRH by antagonizing a-melanocyte-stimulating hormone and thereby opposing the action of leptin. Thus, the central melanocortin system is well posited to mediate the actions of leptin on the thyroid axis. Thus, animal 46 and human 17 studies suggest that hypothalamic-pituitary-thyroid activity in response to increased leptin levels in obesity might serve as a check for further weight gain through the metabolic actions of thyroid hormones. In studies of the effects of leptin administration on TSH, findings differed depending on whether basal TSH concentrations or TSH secretion were examined. For example, administration of leptin to leptindeficient children 47 and healthy adults 48 increases thyroid hormones without altering basal TSH concentration. In contrast, leptin replacement significantly blunts the 24-hour TSH (µU/ml) 24-hour leptin (ng/ml) Figure 3 Linear relationship between mean 24-h levels of leptin and TSH in 16 morbidly obese subjects basally (open circles), in 7 morbidly obese subjects after 6 months of surgery (filled circles) and in lean control subjects (filled triangles). TSH, thyrotropic hormone.
Pituitary hormones and bariatric surgery S Camastra et al fasting-induced reduction of TSH secretion in healthy lean men 49 and women. 50 In line with these results, healthy, normal-weight adults the diurnal variation of TSH and leptin secretion are synchronous, suggesting a partial TSH regulation by leptin. 51 The direct relationships between 24-h TSH and adiposity indices as well as 24-h leptin are in agreement with other studies. 17, 38, 52 In our dataset, the latter relationship remained statistically significant after adjusting for sex, BMI, waist and FFM but was lost after adjusting for FM, 17, 52 suggesting that mechanisms other than leptin modulate TSH concentrations in morbidly obese patients.
In agreement with other studies that have shown a significant decrease in serum TSH through weight loss, 53, 54 in our patients TSH levels were significantly reduced after surgery; this occurred jointly with a near-normalization of leptin levels. Alagna et al. 19 did not find changes in TSH levels 12 months after biliopancreatic diversion, while Chikunguwo et al. 55 and Moulin de Moraes et al. 56 did (using gastric bypass). All these studies used basal TSH concentration, whereas we used mean 24-h TSH levels to account for pulsatility. That, in addition to the reduction in FM, a starvation-like effect also played a part in the fall of TSH levels is a possibility. In fact, starvation acts, at least in part, by suppressing TRH expression in the PVN; TSH production falls, followed by a drop in T 4 and T 3 levels. 57 However, patients subjected to biliopancreatic diversion eat normal diets; thus, malabsorption rather than undereating should generate 'starvation' signals to the midbrain. In any case, a drop in circulating leptin levels stands out as the dominant, and perhaps sufficient, signal-suppressing TRH in the PVN. 41 With regard to this, it is to be noted that surgery-induced weight loss essentially normalized serum leptin concentrations despite the persistence of obesity, indicating that mechanisms other than adipose mass contribute to leptin secretion. One such mechanism could be insulin sensitivity, which was fully restored after surgery. 58 
